Mirati Therapeutics (MRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -523,403 | -361,499 | -184,586 | -740,867 | -538,392 |
| Depreciation Amortization | -13,183 | -8,415 | -4,093 | -1,271 | 1,887 |
| Accounts receivable | -13,786 | -9,658 | -5,362 | -865 | 0 |
| Other Working Capital | -59,528 | -36,928 | -48,576 | -10,104 | -26,991 |
| Other Operating Activity | 144,605 | 94,918 | 52,435 | 182,537 | 121,726 |
| Operating Cash Flow | $-465,295 | $-321,582 | $-190,182 | $-570,570 | $-441,770 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 854,934 | 575,430 | 195,420 | 230,654 | 889,918 |
| PPE Investments | -1,027 | -991 | -269 | -4,851 | -4,041 |
| Purchase Of Investment | -705,418 | -363,756 | N/A | N/A | -719,371 |
| Investing Cash Flow | $148,489 | $210,683 | $195,151 | $225,803 | $166,506 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 340,270 | 5,570 | 1,727 | 166,944 | 161,024 |
| Financing Cash Flow | $340,270 | $5,570 | $1,727 | $166,944 | $161,024 |
| Exchange Rate Effect | -6 | -65 | -31 | N/A | N/A |
| Beginning Cash Position | 235,880 | 235,880 | 235,880 | 413,703 | 413,703 |
| End Cash Position | 259,338 | 130,486 | 242,545 | 235,880 | 299,463 |
| Net Cash Flow | $23,458 | $-105,394 | $6,665 | $-177,823 | $-114,240 |
| Free Cash Flow | |||||
| Operating Cash Flow | -465,295 | -321,582 | -190,182 | -570,570 | -441,770 |
| Capital Expenditure | -1,027 | -991 | -269 | -4,851 | -4,041 |
| Free Cash Flow | -466,322 | -322,573 | -190,451 | -575,421 | -445,811 |